Popular Articles on Drug Delivery:
USFDA Unveils Two Draft Guidelines For Generic Development Of Transdermal And Topical Dosage FormsThe United States Food and Drug Administration (USFDA) today 9th October 2018, Read More
|
Intranasal administration route for protein & peptide mucosal delivery. Due to its unique physiology and ready accessibility, the nasal cavity is an attractive delivery site for the systemic administration of therapeutics. The nasal membrane or mucosa Read More
|
Carriers used in Drug Targeting- Niosomes non-ionic surfactant vesicles are similar to liposomes and can be prepared with cholesterol, a surfactant such as polysorbates (tweens) or sorbitanesters of fatty acids (spans) and water. Read More
|
Continuous Improvement in Cancer Therapy & Healthcare System Services Today I read a report in Stat News about the first ‘digital pill’ that has been rolled out at a Cancer Treatment center in Minnesota US. Read More
|
BUCCAL DELIVERY OF PEPTIDES- I The presence of a smooth and relatively immobile surface for placement of a bioadhesive dosage form, the buccal region appears to be more suitable Read more
|
Advances in pharmaceutical research- use of nanotechnology as therapeutic platforms for disease management.New nanoparticles deliver bigger drug payload. Read More
|
Pulmonary route for mucosal drug delivery- I Choosing the lungs to deliver drugs beyond airways is not new. Nicotine and other anesthetics have been delivered to the blood stream this way for many years. Read More
|
Pulmonary route for mucosal drug delivery- IIDry powder inhalers (DPIs) are breath-actuated devices, by virtue of the fact that the kinetic energy imparted to the drug comes from the patient inhaling Read More
|
Nanotechnology in Mucosal Drug Delivery SystemsA new generation of drug delivery systems is being created as a result of the ability to design nano particles and their matrixes. Nano particles are very small molecules Read More
|
FDA Approves First-Ever Human Test Of Embryonic Stem Cell-Based Therapy.
The USFDA has approved "the world's first authorized test in people of a therapy derived from human embryonic stem cells." The clinical trial "could offer the first Read More
|
Innovative Strategies and Models for R&D Success.Over the last quarter of the twentieth century, medical research made substantial advances in defining our understanding of diseases, their etiologies, and the biochemical pathways through which they were mediated. Read More
|
Mucosal Drug Delivery Systems- Part 1: Formulation Considerations
Mucoadhesive drug delivery systems utilize the property of bioadhesion of certain water-soluble polymers, which become adhesive on hydration and hence can be used for targeting a drug to a particular region Read More
|
Formulation considerations in mucosal drug delivery-II The rational approach for developing innovative polypeptide delivery system must therefore initially address two basic questions Read More
|
Formulation Considerations In Mucosal Drug Delivery Systems - IIISeveral test methods have been reported for studying mucoadhesives. These tests are necessary not only to screen a large number of candidate mucoadhesives Read More
|
Formulation considerations in mucosal drug delivery- IV To ensure efficacy and safety of a drug product, the active compound and its degraded product(s) must be quantified to determine the expiry period Read More
|
Novel Oral Controlled Drug Delivery SystemsTechnology in the field of controlled delivery has gone forward at a rapidly accelerating pace and promises many new and exciting developments. Read More
|
Analytical considerations of mucosal drug delivery systemsAs is the case with classical chemical substances, drug and diagnostic products Read More
|
Medical robots market is expected to reach USD 11.4 Billion by 2020 at CARG of 22.2% Medical robots, an emerging field in healthcare is causing a paradigm shift in healthcare as it improves Read More
|
Controlled Release Drug Delivery Systems.The deployment of drugs within the body is becoming more precise with the advent of rate-controlled dosage forms Read More
|
Lean Innovation, Hoshin Kanrii and Six Sigma (as DFSS) for Product Design, Development and Manufacture via 3D Printing; a Case StudyLean Innovation, Hoshin Kanrii and Six Sigma (DFSS- design for six sigma) for product design, development Read More
|
Lean Manufacturing in Food, Drug, Cosmetics & Chemical Industry - A Case StudyImproved productivity of pellet manufacturing (MUPS) by 28% per shift via LEAN Read More
|
7 Important tools to identify a "Quality" problem. There are seven main tools that help identify quality problems. These techniques are the most commonly used and most effective tools for overcoming problems in terms of quality. The best tools are ones that can Read More
|
Improved treatment and wound healing for burn patients at a hospital in France. Expedited patient recovery by 33%: Healthcare Continuous Improvement Case Study Healthcare is a service-based industry sector. Unlike other industries, healthcare has a lot of human angle to it Read More
|
Mistake-Proofing Pharmaceutical Products: What can we learn from Valsartan, Losartan and Irbesartan recalls? First Valsartan, now Irbesartan formulations are going thru a recall. As these product recalls are happening world-over, the chaos is enormous Read More
|
Out of Specification Impurity and Non-Compliance to Manufacturing Standards Continue to Haunt Pharmaceuticals- The Lupin Story. Here's One Way to Correct the MessOut of specification impurity continues to haunt pharmaceutical products Read More
|
Mistake-Proofing Pharmaceutical Product Development, Manufacturing and Logistics, Cost Savings via Poka Yoke Do you have any of the following complaints such as - R&D is slow, doesn’t give out products on time? Or too many failed batches in pilot plant during tech-transfer? Read More
|
Valsartan, Irbesartan, Losartan Product Recalls- What are the Lessons for Pharmaceutical Industry? Since September last year, news of *SARTAN drug recalls are doing the rounds Read More
|
